New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 17, 2014
07:23 EDTAUXLUBS calls Auxilium a 'sleeper pick' for 2014
UBS believes investors are overlooking Auxilium's highly leveraged business model which will be driven by strong Xiaflex, Stendra, and Testopel growth, and stabilizing Testim. The firm expects operating margins to move towards 30% by 2016-17 from approximately 10% in 2013 and a pathway for 30% stock return performance over the next year. Shares are Buy rated with a $30 price target, up from $23.
News For AUXL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 27, 2015
09:35 EDTAUXLAuxilium shareholders approve merger with Endo
Subscribe for More Information
January 22, 2015
14:03 EDTAUXLAuxilium to host special shareholder meeting
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use